Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2009 1
2011 1
2012 1
2013 2
2014 1
2015 3
2016 1
2017 1
2018 4
2019 4
2020 3
2021 4
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean lihua wang (1,438 results)?
Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis.
Han W, Wang L, Li C, Chen J, Zhang W, Wang X, Pang Q, Zhao Y, Sun X, Zhang K, Li G, Li L, Qiao X, Liu M, Wang Y, Deng L, Wang W, Bi N, Zhang T, Deng W, Ni W, Chang X, Zhou Z, Liang J, Feng Q, Wang L, Chen D, Lv J, Zhu S, Han C, Xiao Z. Han W, et al. Among authors: wang l. Ther Adv Med Oncol. 2022 Oct 28;14:17588359221131526. doi: 10.1177/17588359221131526. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36324733 Free PMC article.
Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy.
Gao LR, Li C, Han W, Ni W, Deng W, Tan L, Zhou Z, Chen D, Feng Q, Liang J, Lv J, Wang W, Liu W, Deng L, Wang X, Zhang T, Wang J, Zhai Y, Bi N, Wang L, Hui Z, Li YX, Xiao Z. Gao LR, et al. Among authors: wang l. Ther Adv Med Oncol. 2022 Jul 26;14:17588359221108693. doi: 10.1177/17588359221108693. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35923925 Free PMC article.
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy.
Chang X, Chen J, Zhang W, Yang J, Yu S, Deng W, Ni W, Zhou Z, Chen D, Feng Q, Lv J, Liang J, Hui Z, Wang L, Lin Y, Chen X, Xue Q, Mao Y, Gao Y, Wang D, Feng F, Gao S, He J, Xiao Z. Chang X, et al. Among authors: wang l. Ther Adv Med Oncol. 2021 Dec 20;13:17588359211061948. doi: 10.1177/17588359211061948. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34987617 Free PMC article.
The status of medical physics in radiotherapy in China.
Yan H, Hu Z, Huang P, Men K, Zhang Y, Wang LH, Li YX, Dai JR, Hu YM. Yan H, et al. Phys Med. 2021 May;85:147-157. doi: 10.1016/j.ejmp.2021.05.007. Epub 2021 May 16. Phys Med. 2021. PMID: 34010803 Review.
Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG Survey.
Li C, Wang X, Wang L, Chen J, Zhang W, Pang Q, Zhao Y, Sun X, Zhang K, Li G, Li L, Qiao X, Liu M, Wang Y, Deng L, Wang W, Bi N, Zhang T, Deng W, Ni W, Chang X, Han W, Zhou Z, Liang J, Feng Q, Wang L, Chen D, Lv J, Zhu S, Han C, Xiao Z. Li C, et al. Among authors: wang l. Acta Oncol. 2021 May;60(5):627-634. doi: 10.1080/0284186X.2021.1902564. Epub 2021 Apr 1. Acta Oncol. 2021. PMID: 33793382
Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial.
Xie C, Jing Z, Luo H, Jiang W, Ma L, Hu W, Zheng A, Li D, Ding L, Zhang H, Xie C, Lian X, Du D, Chen M, Bian X, Tan B, Xia B, Xie R, Liu Q, Wang L, Wu S. Xie C, et al. Among authors: wang l. Br J Cancer. 2020 Nov;123(11):1616-1624. doi: 10.1038/s41416-020-01054-6. Epub 2020 Sep 22. Br J Cancer. 2020. PMID: 32958820 Free PMC article. Clinical Trial.
31 results